Home/Filings/4/0000899243-23-001577
4//SEC Filing

Alloway Paul 4

Accession 0000899243-23-001577

CIK 0001661998other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 4:05 PM ET

Size

5.3 KB

Accession

0000899243-23-001577

Insider Transaction Report

Form 4
Period: 2023-01-09
Alloway Paul
See Remarks
Transactions
  • Sale

    Common Stock

    2023-01-09$1.39/sh3,090$4,29620,103 total
Footnotes (2)
  • [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
  • [F2]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.39 to $1.40. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.

Issuer

Homology Medicines, Inc.

CIK 0001661998

Entity typeother

Related Parties

1
  • filerCIK 0001916155

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:05 PM ET
Size
5.3 KB